Table 2.
Item | Control group | Treated groupa | SE | ||
---|---|---|---|---|---|
GGSL | GGSM | GGSH | |||
GGS Dose (%, w/w) | 0 | 0.5% | 1% | 2% | |
GOT (UL−1) | 195.3 | 171.3 | 183.8 | 182.5 | 13.4 |
GPT (UL−1) | 7.7 | 6.8 | 7.7 | 6.8 | 0.8 |
Cholesterol (md dL−1) | 109.3 | 90.8* | 83.8* | 80.7* | 5.9 |
Triglycerides (md dL−1) | 27.8 | 33.5 | 21.3 | 24.8 | 6.9 |
BUN (md dL−1) | 2.4 | 1.9* | 1.6* | 1.6* | 0.2 |
Creatinine (md dL−1) | 0.28 | 0.23 | 0.20* | 0.25 | 0.02 |
aGGSL: low dose of GGS; GGSM: medium dose of GGS; GGSH: high dose of GGS.
*Significant difference (P < .05 versus control group).